Cargando…
Rae1 drives NKG2D binding‐dependent tumor development in mice by activating mTOR and STAT3 pathways in tumor cells
Natural killer group 2 member D (NKG2D) ligands (NKG2DLs) on tumor cells engage NKG2D and mediate killing by NKG2D(+) immune cells. However, tumor cells with high levels of NKG2DLs are still malignant and proliferate rapidly. We investigated the reason for NKG2DL‐expressing cell progression. Tumor c...
Autores principales: | Zhao, Peiyan, Yang, Lei, Li, Xin, Lu, Wenting, Lu, Fangjie, Wang, Shengnan, Wang, Ying, Hua, Li, Cui, Cuiyun, Dong, Boqi, Yu, Yongli, Wang, Liying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385386/ https://www.ncbi.nlm.nih.gov/pubmed/32333709 http://dx.doi.org/10.1111/cas.14434 |
Ejemplares similares
-
Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice
por: Hua, Li, et al.
Publicado: (2016) -
Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages
por: Thompson, Thornton W, et al.
Publicado: (2018) -
The NKG2D Ligands RAE-1δ and RAE-1ε Differ with Respect to Their Receptor Affinity, Expression Profiles and Transcriptional Regulation
por: Cédile, Oriane, et al.
Publicado: (2010) -
NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid‐derived suppressor cells in mice
por: Qian, Li, et al.
Publicado: (2017) -
STAT3 and mTOR: co-operating to drive HIF and angiogenesis
por: Dodd, Kayleigh M., et al.
Publicado: (2015)